Literature DB >> 35911064

A double heterozygous variant in MYH6 and MYH7 associated with hypertrophic cardiomyopathy in a Japanese Family.

Takanori Suzuki1,2, Kazuyoshi Saito1,2, Tetsushi Yoshikawa2, Keichi Hirono3, Yukiko Hata4, Naoki Nishida4, Kazushi Yasuda1, Masami Nagashima1.   

Abstract

Hypertrophic cardiomyopathy (HCM) is genetically heterogeneous. Different variants associated with HCM have been identified in several cardiac sarcomeric protein genes. We identified the heterozygous missense variant c.2191 C>A p. Pro 731 Thr in the MYH7 gene and the heterozygous frameshift variant c.1091-1092 insTGAA p.Lys364fs*in the MYH6 gene in a Japanese family. Family members with the double variants demonstrated severe phenotypes, such as sudden cardiac-related death and heart failure. These double variants were well segregated and might be responsible for the severity of cardiovascular events in affected family members. These double variants are potentially associated with specific phenotypes in HCM. Further studies are needed to analyze specific gene functions. <Learning objective: Hypertrophic cardiomyopathy (HCM) is genetically heterogeneous and is associated with different variants in sarcomeric protein genes. We identified a heterozygous missense variant in the MYH7 gene and a heterozygous frameshift variant in the MYH6 gene in a Japanese family. These double variants are potentially associated with specific phenotypes in HCM.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac sarcomeric protein genes; Heterozygous missense variant; Hypertrophic cardiomyopathy

Year:  2021        PMID: 35911064      PMCID: PMC9326009          DOI: 10.1016/j.jccase.2021.09.011

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.

Authors:  Elisa Carniel; Matthew R G Taylor; Gianfranco Sinagra; Andrea Di Lenarda; Lisa Ku; Pamela R Fain; Mark M Boucek; Jean Cavanaugh; Snjezana Miocic; Dobromir Slavov; Sharon L Graw; Jennie Feiger; Xiao Zhong Zhu; Dmi Dao; Debra A Ferguson; Michael R Bristow; Luisa Mestroni
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

2.  Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.

Authors:  Hideshi Niimura; Kristen K Patton; William J McKenna; Johann Soults; Barry J Maron; J G Seidman; Christine E Seidman
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

Review 3.  New perspectives on the prevalence of hypertrophic cardiomyopathy.

Authors:  Christopher Semsarian; Jodie Ingles; Martin S Maron; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2015-03-31       Impact factor: 24.094

Review 4.  Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron; Ethan J Rowin; Martin S Maron
Journal:  Circ Res       Date:  2019-08-01       Impact factor: 17.367

5.  Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.

Authors:  Charlotte Burns; Richard D Bagnall; Lien Lam; Christopher Semsarian; Jodie Ingles
Journal:  Circ Cardiovasc Genet       Date:  2017-08

6.  Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.

Authors:  Julia Daher Carneiro Marsiglia; Flávia Laghi Credidio; Théo Gremen Mimary de Oliveira; Rafael Ferreira Reis; Murillo de Oliveira Antunes; Aloir Queiroz de Araujo; Rodrigo Pinto Pedrosa; João Marcos Bemfica Barbosa-Ferreira; Charles Mady; José Eduardo Krieger; Edmundo Arteaga-Fernandez; Alexandre da Costa Pereira
Journal:  Am Heart J       Date:  2013-09-18       Impact factor: 4.749

7.  Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.

Authors:  J Mathew; L Zahavich; M Lafreniere-Roula; J Wilson; K George; L Benson; S Bowdin; S Mital
Journal:  Clin Genet       Date:  2017-12-26       Impact factor: 4.438

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  A Wide and Specific Spectrum of Genetic Variants and Genotype-Phenotype Correlations Revealed by Next-Generation Sequencing in Patients with Left Ventricular Noncompaction.

Authors:  Ce Wang; Yukiko Hata; Keiichi Hirono; Asami Takasaki; Sayaka Watanabe Ozawa; Hideyuki Nakaoka; Kazuyoshi Saito; Nariaki Miyao; Mako Okabe; Keijiro Ibuki; Naoki Nishida; Hideki Origasa; Xianyi Yu; Neil E Bowles; Fukiko Ichida
Journal:  J Am Heart Assoc       Date:  2017-08-30       Impact factor: 5.501

10.  A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.

Authors:  Anastasia Miron; Myriam Lafreniere-Roula; Chun-Po Steve Fan; Katey R Armstrong; Andreea Dragulescu; Tanya Papaz; Cedric Manlhiot; Beth Kaufman; Ryan J Butts; Letizia Gardin; Elizabeth A Stephenson; Taylor S Howard; Pete F Aziz; Seshadri Balaji; Virginie Beauséjour Ladouceur; Lee N Benson; Steven D Colan; Justin Godown; Heather T Henderson; Jodie Ingles; Aamir Jeewa; John L Jefferies; Ashwin K Lal; Jacob Mathew; Emilie Jean-St-Michel; Michelle Michels; Stephanie J Nakano; Iacopo Olivotto; John J Parent; Alexandre C Pereira; Christopher Semsarian; Robert D Whitehill; Samuel G Wittekind; Mark W Russell; Jennifer Conway; Marc E Richmond; Chet Villa; Robert G Weintraub; Joseph W Rossano; Paul F Kantor; Carolyn Y Ho; Seema Mital
Journal:  Circulation       Date:  2020-05-18       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.